Dreyling, M., Doorduijn, J., Giné, E., Jerkeman, M., Walewski, J., Hutchings, M., ... & Hoster, E. (2024). Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. The Lancet, 403(10441), 2293-2306.

Fukuhara, S. (2024). Update on treatment strategies for mantle cell lymphoma. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 65(9), 1012-1018.

Pla, C., Solans, M., Ameijide, A., Sanvisens, A., Carulla, M., Rojas, M. D., ... & REDECAN working group. (2022). Incidence and survival of lymphoid neoplasms in Spain, 2002-2013: A population-based study from the Spanish Network of Cancer Registries (REDECAN). Frontiers in oncology, 12, 1046307